- Home
- ACRS vs ALTG Comparison
ACRS vs ALTG Comparison
Compare ACRS & ALTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRS
- ALTG
- Stock Information
- Founded
- ACRS 2012
- ALTG 1984
- Country
- ACRS United States
- ALTG United States
- Employees
- ACRS N/A
- ALTG N/A
- Industry
- ACRS Biotechnology: Pharmaceutical Preparations
- ALTG Industrial Machinery/Components
- Sector
- ACRS Health Care
- ALTG Industrials
- Exchange
- ACRS Nasdaq
- ALTG Nasdaq
- Market Cap
- ACRS 198.2M
- ALTG 206.7M
- IPO Year
- ACRS 2015
- ALTG N/A
- Fundamental
- Price
- ACRS $2.31
- ALTG $5.94
- Analyst Decision
- ACRS Strong Buy
- ALTG Hold
- Analyst Count
- ACRS 9
- ALTG 3
- Target Price
- ACRS $9.25
- ALTG $11.67
- AVG Volume (30 Days)
- ACRS 1.3M
- ALTG 158.9K
- Earning Date
- ACRS 11-06-2025
- ALTG 11-07-2025
- Dividend Yield
- ACRS N/A
- ALTG 3.84%
- EPS Growth
- ACRS N/A
- ALTG N/A
- EPS
- ACRS N/A
- ALTG N/A
- Revenue
- ACRS $16,789,000.00
- ALTG $1,851,100,000.00
- Revenue This Year
- ACRS N/A
- ALTG $1.30
- Revenue Next Year
- ACRS N/A
- ALTG $3.26
- P/E Ratio
- ACRS N/A
- ALTG N/A
- Revenue Growth
- ACRS N/A
- ALTG N/A
- 52 Week Low
- ACRS $1.05
- ALTG $3.54
- 52 Week High
- ACRS $5.17
- ALTG $8.99
- Technical
- Relative Strength Index (RSI)
- ACRS 62.06
- ALTG 34.42
- Support Level
- ACRS $2.24
- ALTG $6.27
- Resistance Level
- ACRS $2.47
- ALTG $6.88
- Average True Range (ATR)
- ACRS 0.19
- ALTG 0.28
- MACD
- ACRS 0.03
- ALTG -0.01
- Stochastic Oscillator
- ACRS 77.92
- ALTG 2.08
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.